Table 4 Summary of MI studies.
Animals | Injury | OMSCs | Administration | Dose | Outcomes | Improved functional outcomes (compared to control group) | References |
|---|---|---|---|---|---|---|---|
Rats | Permanent ligation of the left descending coronary artery | hDPSCs | Intramyocardial transplantation | 1.5*106 cells | 1. Improved functional outcomes (1/1); 2. Cells not differentiated into cardiac or smooth muscle cells; 3. Increased vascular density; 4. Reduced infarcted area | Echocardiographic test (measured cardiac function) | |
Mice | Left anterior descending artery (LAD) was ligated for 30 min, then loosened for reperfusion | SHED-CM | Infused systemically via the jugular vein | 500 µl CM | 1. Reduced infarct area; 2. Suppressed apoptosis; 3. Suppressed inflammatory responses | ||
Rabbits | Permanent left circumflex coronary artery was ligated | SHED | Intravenously through rabbit marginal ear vein | 1*106 cells | 1. Reduced infarct area; 2. Increased myocardial cells and neovascularization; 3. Improved functional outcomes (1/3) | Heart rate test (measured cardiac function) | |
Rats | Permanent ligation of the left anterior descending (LAD) coronary artery | hDPSCs-extracellular vesicles (EVs) | Intramyocardial injection | 2.5*109 particles/ mL | 1. Reduced infarct size; 2. Decreased the expression of M1 markers in the infarct area; 3. Reduced the infiltrating M1 macrophages in the infarcted area |